Reuters logo
BRIEF-MediWound successfully completes second cohort of EscharEx phase 2 study
September 1, 2017 / 12:11 PM / 3 months ago

BRIEF-MediWound successfully completes second cohort of EscharEx phase 2 study

Sept 1 (Reuters) - Mediwound Ltd

* MediWound successfully completes second cohort of EscharEx phase 2 study

* MediWound Ltd - ‍overall patient demographics and wound baseline characteristics were comparable across both arms in study​

* MediWound - ‍related systemic adverse events were reported & adverse events related to local application were mild to moderate, reversible & resolved during trial​

* MediWound Ltd - ‍intend to initiate EscharEx U.S. phase 3 pivotal program in first half of 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below